| 项目编号 |
PRJCA025546 |
| 项目标题 |
Study of TDXd vs Investigator's Choice Chemotherapy in HER2 low, Hormone Receptor Positive Breast Cancer Patients whose Disease has Progressed on Endocrine Therapy in the Metastatic Setting |
| 涉及领域 |
Medical |
| 数据类型 |
Transcriptome or Gene expression
|
| 物种名称 |
Homo sapiens
|
| 描述信息 |
This is a phase 3 randomized, multi center, open label study. This study is designed to compare T-DXd against investigator's choice single agent chemotherapy to determine if T-DXd can improve outcomes in HR+ HER2 low breast cancer patients whose disease has progressed on at least 2 lines of prior ET in the metastatic setting. |
| 样品范围 |
Multiisolate |
| 发布日期 |
2024-04-23 |
| 项目资金来源 |
| 机构 |
项目类型 |
授权项目ID |
授权项目名称 |
| Astrazeneca
|
|
NA
|
|
|
|
| 提交者 |
Xichun
Hu (xchu2009@hotmail.com)
|
| 提交单位 |
Fudan University Shanghai Cancer Center |
| 提交日期 |
2023-10-23 |
